ArticleInternational journal of clinical and experimental pathology2015

Decreased peritherapeutic VEGF expression could be a predictor of responsiveness to first-line FOLFIRI plus bevacizumab in mCRC patients.

Hsiang-Lin Tsai et al.PubMed ↗Full text ↗

No numbers read from the abstract.